
Deoxynojirimycin hydrochloride (DNJ HCL) is an orally effective α-glucosidase inhibitor. DNJ HCL can suppress postprandial blood glucose levels and help prevent diabetes. It possesses multiple functions, including lowering blood sugar, promoting weight loss, and exhibiting antiviral activity. With increasing research in these areas, DNJ has gradually gained public attention.
DNJ is a potent α-glucosidase inhibitor. It structurally resembles glucose and competitively binds to digestive enzymes responsible for carbohydrate breakdown.
Mechanism of Action: inhibits α-glucosidase activity in the small intestine; delays conversion of complex carbohydrates into absorbable glucose; slows glucose absorption after meals; reduces postprandial blood glucose spikes; supports insulin sensitivity and glucose utilization; promotes GLP-1 related metabolic benefits; helps reduce metabolic stress associated with obesity and aging.

Blood Glucpse Control
Helps maintain healthy blood sugar levels after meals by slowing carbohydrate conversion to glucose, resulting in reduced glucose spikes and better glycemic control.
Weight Management
Supports healthy body weight and appetite regulation; research suggests DNJ influences GLP-1 related pathways and improves glucose metabolism.This helps reduce fat accumulation and improve energy utilization.
Insulin Sensitivity Support
It helps improve insulin function and glucose uptake. Studies have shown that DNJ can promote insulin secretion, and reduce insulin resistance associated with metabolic disorders.
Healthy Aging
By promoting glucose homeostasis, it may help reduce oxidative stress and glycation-related metabolic aging processes.

Product Name: Dihydroberberine
CAS No.: 483-15-8
Purity: ≥ 97.0% HPLC
Assay: ≥ 97.0% HPLC
Appearance: Yellow Fine Powder
Certification: ISO9001/FSSC22000/HALAL/KOSHER
Product Name: Deoxynojirimycin Hydrochloride
CAS No.: 73285-50-4
Purity: ≥ 99.9% HPLC
Assay: ≥ 99.9% HPLC
Appearance: White Crystalline Powder
Certification: ISO9001/FSSC22000/HALAL/KOSHER